NR3C1 and depressive symptom measurement: In depression, about 50% of patients display hyperactivity of the HPA-axis as represented by basal hypercortisolemia and resistance to GR-mediated suppression of glucocorticoid levels (Checkley, 1996; Pariante and Miller, 2001).